Laboratory colonies of oriental fruit moth, Grapholita molesta (Busck) (Lepidoptera: Tortricidae), were reared on ‘Gala’ apples (Malus pumila Mill.) and lima bean (Phaseolus lunatus L.) diet. Neonates were placed on wheat germ diet containing a range of concentrations of esfenvalerate or lambda-cyhalothrin; mortality was assessed after 96 h. For a long-term laboratory colony, LC50 values of esfenvalerate and lambda-cyhalothrin were 0.35 and 0.12 ppm, respectively, for progeny of insects reared on apples. For a colony established from Calhoun Co., IL, in 2007, LC50 values of esfenvalerate and lambda-cyhalothrin were 0.37 and 0.10 ppm, respectively, for progeny of insects reared on apples. LC50 values of these insecticides did not differ significantly for either colony when progeny of insects reared on lima bean diet were tested. We observed no consistent evidence of pyrethroid resistance in the Calhoun colony after laboratory culture for 21–23 generations. We described the dose-response relationship for esfenvalerate applied topically in 1 µl of acetone to male moths from the long-term laboratory colony and estimated the LD99 to be 0.022 µg per moth. Application of 0.022 µg of esfenvalerate per moth to ≈ 600 male moths from two putatively susceptible populations resulted in mean survivorship approximately equal to the expected level of 1.0%. Application of the same dose to 374 field-captured moths from two Calhoun Co. orchards with histories of pyrethroid use resulted in mean survivorship of 9.4 and 82%. We propose that 0.022 µg of esfenvalerate in 1 µl of acetone can be used as a diagnostic dose for monitoring pyrethroid resistance in oriental fruit moth in the field.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 104 • No. 3